Comparação entre o sistema automatizado e PCR na identificação e susceptibilidade de isolados clínicos de Enterococcus spp

Enterococci are increasingly responsible for nosocomial infections worldwide. This study was undertaken to compare the identification and susceptibility profile using an automated MicrosScan system, PCR-based assay and disk diffusion assay of Enterococcus spp. We evaluated 30 clinical isolates of Enterococcus spp. Isolates were identified by MicrosScan system and PCR-based assay. The detection of antibiotic resistance genes (vancomycin, gentamicin, tetracycline and erythromycin) was also determined by PCR. Antimicrobial susceptibilities to vancomycin (30 µg), gentamicin (120 µg), tetracycline (30 µg) and erythromycin (15 µg) were tested by the automated system and disk diffusion method, and were interpreted according to the criteria recommended in CLSI guidelines. Concerning Enterococcus identification the general agreement between data obtained by the PCR method and by the automatic system was 90.0% (27/30). For all isolates of E. faecium and E. faecalis we observed 100% agreement. Resistance frequencies were higher in E. faecium than E. faecalis. The resistance rates obtained were higher for erythromycin (86.7%), vancomycin (80.0%), tetracycline (43.35) and gentamicin (33.3%). The correlation between disk diffusion and automation revealed an agreement for the majority of the antibiotics with category agreement rates of >; 80%. The PCR-based assay, the van(A) gene was detected in 100% of vancomycin resistant enterococci. This assay is simple to conduct and reliable in the identification of clinically relevant enterococci. The data obtained reinforced the need for an improvement of the automated system to identify some enterococci.Os enterococos são cada vez mais responsáveis por infecções hospitalares em todo o mundo. Este estudo foi realizado para comparar a identificação e perfil de suscetibilidade entre o sistema automatizado MicrosScan e a técnica molecular de PCR em espécies de Enterococcus spp. Foram avaliados 30 isolados clínicos de Enterococcus spp. Os isolados foram identificados pelo sistema MicrosScan® e pela técnica de PCR. A detecção de genes de resistência a antibióticos (vancomicina, gentamicina, tetraciclina e eritromicina) foi determinada por PCR. Suscetibilidades antimicrobianas à vancomicina (30 µg), gentamicina (120 µg), tetraciclina (30 µg) e eritromicina (15 µg), foram testados pelos métodos automatizados e pelo disco difusão, de acordo com as orientações do CLSI. No que diz respeito à identificação de Enterococcus em geral entre os dados obtidos pelo método de PCR e pelo sistema automático foi de 90,0% (27/30). Para todos os isolados de E. faecium e E. faecalis observamos concordância de 100%. Freqüências de resistência foi maior em E. faecium do que em E. faecalis. As taxas de resistência obtidas foi maior para eritromicina (86,7%), vancomicina (80,0%), tetraciclina (43,35%) e gentamicina (33,3%). A correlação entre a técnica de disco difusão e automação revelou-se de acordo para maioria dos antibióticos com taxas >; 80%. O gene van(A) foi detectado em 100% dos Enterococcus resistentes á vancomicina. O ensaio baseado em PCR é de simples realização e de confiança para identificação de enterococos clinicamente relevantes. Os dados obtidos reforçam a necessidade de melhoria no sistema automatizado para identificar alguns enterococos

Fast detection of Mycobacterium tuberculosis in culture-positive sputum samples by nitrate reductase activity

Microscopy and bacterial culture are the main tools in the diagnosis of tuberculosis. Since the slow growth of Mycobacterium tuberculosis impairs rapid diagnosis strategies, especially in countries where the latter are the only available resources, the ongoing development of new and inexpensive tools based on mycobacterial metabolism optimizing growth detection with preliminary identification is greatly welcome. When compared to the other species from the M. tuberculosis complex, M. tuberculosis is a strong nitrate reducer. Current assay compares the nitrate reductase activity of M. tuberculosis from pulmonary specimens cultivated in nitrate-supplemented media. Fifty-five sputum samples were decontaminated and inoculated in conventional (Middlebrook 7H9, Ogawa Kudoh-OK) and in nitrate-supplemented media (Middlebrook 7H9-N, Ogawa Kudoh-N). An aliquot from the media directly reacted with Griess reagent (7H9-N and OK-N) every five days, or transferred to a nitrate substrate solution (7H9, OK). Nitrate to nitrite reduction was considered positive, revealed by the pink color, indicating bacterial growth. As reference method, the Mycobacteria Growth Indicator Tube (MGIT) was used for sensitivity calculations and statistical analysis. 7H9-N and OK-N assays proved to perform better in detecting M. tuberculosis than conventional assays (7H9 and OK). Indeed, broth nitrate-supplemented medium (7H9-N) was comparable to MGIT to detect M. tuberculosis, except in growth detection time. Results show that 7H9-N may be used as an alternative tool particularly in low-income countries since it is a simple and cheap technique, and does not restrict diagnosis to single-source products

Molecular characterization of Mycobacterium tuberculosis and Mycobacterium bovis isolates by Enterobacterial Repetitive Intergenic Consensus-PCR

Tuberculosis (TB) is an infectious disease in which the molecular typing methods allow to have important information about the dynamics of transmission and to assist properly in disease control. Although the ERIC-PCR (Enterobacterial repetitive intergenic consensus-PCR) assay is fast and easy to perform, scarce studies have reported its use in epidemiological studies in TB outbreaks. In this study, we aimed to genotype Mycobacterium tuberculosis and M. bovis isolates by ERIC-PCR and compare its discriminatory power with two other classically used methods: 12 loci-MIRU (Mycobacterial Interspersed Repetitive Units) and Spoligotyping. The M. tuberculosis isolates studied were from northwestern and southwestern and M. bovis from northwestern Parana, Brazil. ERIC-PCR rendered banding patterns with great diversity (1 to 12 bands) of molecular sizes, ranging from 100 to 1600 bp. ERIC-PCR showed to be fast, simple and affordable to differentiate isolates. ERIC-PCR would be an important tool in the epidemiology of TB as screening in case of outbreak, which demands rapid intervention. However if any doubt persist, as it may occur with the application of only one genotypic method, other genotyping methods should be applied and carefully interpreted, always with additional epidemiological information

Is the efflux pump inhibitor Verapamil a potential booster for isoniazid against Mycobacterium tuberculosis?

The membrane-based efflux pump systems are recognized to have an important role in pathogenicity and drug resistance in Mycobacterium tuberculosis by the extrusion of toxic substrates and drugs from the inner bacillus. This study aimed to investigate the in vitro interaction of Verapamil (VP), an efflux pump inhibitor, with the classical first-line anti-tuberculosis drug isoniazid (INH) in resistant and susceptible M. tuberculosis clinical isolates. Seven multidrug-resistant (MDR), three INH monoresistant and four susceptible M. tuberculosis clinical isolates were tested for the INH and VP combination by modified Resazurin Microtiter Assay Plate (REMA). Fractional Inhibitory Concentration (FIC) and Modulation Factor (MF) were determined. The INH plus VP combination showed no significant change in the Minimum inhibitory concentration (MIC) values of INH (FIC≥ 0.5; MF=1 or 2).The use of VP in tuberculosis therapy should be managed carefully, considering the resistance caused by specific mutation in katG and inhA genes, in which the use of these EPIs may have no success. The use of EPIs as an adjunctive drug in the anti-tuberculosis therapy should be further investigated on a larger number of M. tuberculosis clinical isolates with different resistant profile

<b>Estudo do perfil de susceptibilidade antimicrobiana e avaliação molecular de amostras de Enterococcus spp isoladas de pacientes hospitalizados</b> - DOI: 10.4025/actascihealthsci.v25i1.2249 <b>Study of drugs susceptibility and molecular samples evaluation of <em>Enterococcus</em> spp isolated in hospitalized patients</b> - DOI: 10.4025/actascihealthsci.v25i1.2249

Neste estudo foi investigado o perfil de susceptibilidade antimicrobiana e avaliação molecular de amostras de <em>Enterococcus</em> spp, isoladas de urina, secreção purulenta, sangue e ferida cirúrgica de pacientes do Hospital Universitário de Maringá, estado do Paraná, no período entre 1998 e 2000. As amostras foram avaliadas quanto à susceptibilidade a drogas, tipificadas através de JB1-PCR e investigadas quanto à presença de gene Van A e Van B. Das 58 amostras, 98,3% foram classificadas como <em>Enterococcus faecalis</em>. Todas as amostras foram sensíveis à nitrofurantoína e vancomicina, 96,6% sensíveis à ampicilina, 32,8% foram resistentes à estreptomicina, 10,3% resistentes à gentamicina e ciprofloxacina e 6,9% resistentes a norfloxacina. Por meio do teste de CIM, para vancomicina, observou-se crescimento bacteriano até a concentração de 4μg/ml. Não foi detectada a presença de gene Van A e Van B. A amplificação por JB1-PCR proporcionou padrões de bandas com até 7 fragmentos sendo as amostras divididas em 6 grupos distintos. Não houve prevalência de algum padrão de bandeamento que denotasse a presença de um clone e não foi possível estabelecer correlação entre genótipo com resistência antimicrobiana.<br>The aim of this study was to investigate the prevalency of <em>Enterococcus</em> spp, isolated from different clinical materials. The strains were evaluated for drugs susceptibility, typing by JB1-PCR and screened to the presence of Van A and Van B gene. From the 58 strains, 98.3% were classified as <em>Enterococcus faecalis</em>. All strains were sensible to nitrofurantoin and vancomycin, 96.6% were sensible to ampicilin, 32.8% were resistant to streptomycin, 10.3% were resistant to gentamicin and ciprofloxacin and 6.9% were resistant to norfloxacin. Using CIM test to check vancomycin susceptibility was observed bacterial growth until 4μg/ml. The presence of Van A e Van B gene was not detected. The amplification by JB1-PCR provided band patterns with up to 7 fragments and the samples were classified into 6 distint groups. The band patterns did not point out prevalence of any clone disseminated among strains. It was not possible to correlate genotype with antimicrobial resistance

Exopolysaccharides from Klebsiella oxytoca: anti-inflammatory activity

Exopolysaccharides (EPS) produced by Klebsiella oxytoca are of environmental, pharmaceutical,and medicinal interest. However, studies about the anti-inflammatory activity of EPS produced bythis microorganism still remain limited. The aim of this study was to produce, characterize, andevaluate the anti-inflammatory activity of EPS from K. oxytoca in a pleurisy model. Colorimetricanalysis revealed that precipitated crude exopolysaccharides (KEPSC) and deproteinatedexopolysaccharides (KEPS) present high levels of total carbohydrates (65.57% and 62.82%,respectively). Analyses of uronic acid (7.90% in KEPSC and 6.21% in KEPS) and pyruvic acid(3.01% in KEPSC and 1.68% in KEPS) confirm that the EPS are acidic. Gas chromatographymass spectrometry analyses demonstrated that the EPS consisted of rhamnose (29.83%), glucose(11.21%), galactose (52.45%), and mannose (6.50%). The treatment of an experimental pleurisymodel in rats through subcutaneous administration of 50, 100, 200, and 400 mg/kg of KEPSdecreased both the volume of inflammatory exudate and the number of leukocytes recruited tothe pleural cavity. The present data showed that EPS production by K. oxytoca using the methoddescribed is easy to perform and results in a good yield. In addition, we show that KEPS exhibitanti-inflammatory activity when administered subcutaneously in rat